Routinely overseeing high profile funding work in the AI and capital investment fields, the ‘great all-round’ outfit at Taylor Wessing is highly experienced in the whole spectrum of financing rounds and bridge financing proceedings. The firm showcases ’depth and expertise’ in the life sciences, tech, and renewable energy industries, consistently drawing upon cross-border insight with Europe and the US. Based out of London, Howard Palmer heads the team, specialising in complex investment round work and M&A transactions, and Josef Fuss acts for tech investors and entrepreneurs. Alexandra Richardson is well-versed in the software, climate tech and digital media sectors, while Cambridge’s Ross McNaughton is an expert in public capital raisings. Ian Moore advises corporations on every stage of the life cycle and Elinor Picton supports individual investors with their investments in fast-growth businesses. Angus Miln left the firm in September 2024.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
- ‘Great all-round team with depth and expertise.’
Key clients
- Apollo Therapeutics
- BeZero Carbon
- Compound Ventures
- Curve
- Dawn Capital
- Equator Africa Fund
- Fresha
- Google Ventures
- HiBob
- NATO Innovation Fund
- Portage Ventures
- Project A Ventures
Work highlights
Advised longstanding client, Vinted on its €340 million secondary share sale.
Advised Compound Ventures in relation to its investment interests in Wayve Technology.
Advised Nuclera, a biotech company accelerating protein expression and purification workflows, on its $75 million series C financing.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Howard Palmer
Alexandra Richardson
Ross McNaughton
Practice head
Howard Palmer
Other key lawyers
Josef Fuss; Alexandra Richardson; Ross McNaughton; Ian Moore; Elinor Picton